Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study sheds new light on post-operative bleeding in newborns

07.03.2016

A new study finds significant differences between the blood clot structure in adults and newborns, helping researchers better understand the challenges in addressing post-operative bleeding in neonatal patients. The researchers also found that the current standard of care for treating post-operative bleeding may pose an increased risk of thrombosis in newborns compared to adults, which researchers hadn't suspected. The study was performed by researchers at North Carolina State University, the University of North Carolina at Chapel Hill, Emory University, Children's Healthcare of Atlanta and the Georgia Institute of Technology.


These are laser scanning confocal microscopy images of clots constructed from adult fibrinogen (A), neonatal fibrinogen (B), or a mixture of the two (C). Scale bar= 20 μm.

Credit: Ashley Brown

"We knew that neonates - infants less than one month old - are more likely than adults to suffer from severe bleeding after heart surgery, which poses a variety of health risks," says Ashley Brown, first author of a paper on the study and an assistant professor in the joint biomedical engineering department at NC State and UNC-Chapel Hill.

"The current standard of care is to give neonatal patients blood products - such as a protein called fibrinogen - derived from adult blood," Brown says. "But neonatal blood and adult blood aren't the same; many of the components involved in clotting in newborns have differing levels of activity, or effectiveness, compared to the same components in adults. Our goal was to better understand how clotting in neonates differs from that in adults, so that we can move closer to developing more effective treatment strategies for these infants."

The researchers' hypothesis was that fibrinogen - the main blood-clotting protein - from neonates would form clots that are different from those formed by adult fibrinogen, and they were correct. However, they were surprised to find that fibrinogen from adults did not integrate well with the fibrinogen in neonates. In other words, the fibrinogen from adults and newborns wouldn't stick to each other and form a clot.

To test this hypothesis, the researchers took samples of neonate fibrinogen and adult fibrinogen and compared how they formed clots. They looked at clots formed solely of adult fibrinogen, clots formed solely of neonate fibrinogen, and clots formed of mixed adult and neonate fibrinogen.

The researchers found that neonate fibrinogen formed less dense, more fragile clots than adult fibrinogen. And they found that a mixture of adult and neonate fibrinogen formed clots that were also fragile and less dense - even if there was relatively little neonate fibrinogen in the mixture.

The researchers also evaluated how long it took these clots to dissolve. This is important because blood clots that don't break down can form thrombosis or be released into the bloodstream and cause a stroke.

The study showed that clots of neonate fibrinogen dissolve about twice as quickly as clots formed from adult fibrinogen. It also showed that clots formed from an adult and neonate fibrinogen mixture dissolved at approximately the same rate as adult-only clots - regardless of the percentage of neonate fibrinogen in the mixture.

"This suggests that using adult fibrinogen in neonatal patients may pose an increased risk of embolism or other adverse thrombotic events," says Nina Guzzetta, MD, corresponding author on the study, associate professor of anesthesiology at Emory University School of Medicine, and a pediatric cardiac anesthesiologist at Children's Healthcare of Atlanta.

"This work drives home that newborns are not just small adults, and we still have much to learn about clotting in neonates," Guzzetta says. "It also tells us that there is a great deal of room for improvement in the current standard of care for post-operative bleeding in neonates.

"We are investigating several approaches that may help address this problem, evaluating various modes of action," Brown says. "It is possible that we can use various external factors that promote clotting to stimulate the fibrinogen in neonates to form a denser clot. We are investigating possible alternatives to help neonates form a better clot after major surgery without having to use adult fibrinogen. For example, we are investigating the use of synthetic platelet-like particles developed by our team to augment hemostasis - the biological process that stops bleeding - in blood samples collected from these patients."

###

The paper, "Fibrin network changes in neonates after cardiopulmonary bypass," was published online March 3 in the journal Anesthesiology. The paper was co-authored by Riley Hannan, now at the University of Virginia; Lucas Timmins and Thomas Barker of the biomedical engineering program at Georgia Tech and Emory; and Janet Fernandez of Children's Healthcare of Atlanta. The work was supported by the Emory University and Children's Healthcare of Atlanta Children's Center for Cardiovascular Biology and by the National Institutes of Health under grant R21EB019068.

Media Contact

Matt Shipman
matt_shipman@ncsu.edu
919-515-6386

 @NCStateNews

http://www.ncsu.edu 

Matt Shipman | EurekAlert!

Further reports about: Healthcare biomedical engineering bleeding clots neonatal

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>